p.1
p.13
p.21
p.35
p.45
p.67
p.73
p.81
Bone Regeneration around Dental Implants as a Treatment for Peri-Implantitis: A Review of the Literature
Abstract:
This manuscript discusses peri-implantitis around dental implants and the current methodologies of surgical and non-surgical approaches towards treating peri-implantitis. Mechanical, chemical cleansing and reactivation of infected implant surface along with recent advances like the use of Laser and Photodynamic therapy (PDT) have also been reviewed in this literature. Bone regenerative treatment methods for the treatment of peri-implantitis using non-resorbable membranes (Guided Bone Regeneration), autogenous bone grafts and bone substitute materials with recombinant human bone morphogenetic protein-2 (rhBMP-2) and other growth factors have also been reviewed in this manuscript.
Info:
Periodical:
Pages:
21-33
Citation:
Online since:
September 2011
Price:
Permissions:
[1] Albrektsson T, Isidor, F. (1994) Consensus report: implant therapy. In: Lang, N. P. & Karring, T. (eds). Proceedings of the 1st European Workshop on Periodontology, p.365–9. Berlin: Quintessence.
[2] Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol. 2008; 35(8): 286-91.
[3] Mombelli A. Etiology, diagnosis, and treatment considerations in peri-implantitis. Curr Opin Periodontol 1997; 4: 127-36.
[4] Donath K. Pathogenesis of bony pocket formation around dental implants. J Dent Assoc S Afr. 1992; 47(5): 204-8.
[5] Adell R, Lekholm U, Rockler B, Brånemark PI, Lindhe J, Eriksson B, Sbordone L. Marginal tissue reactions at osseointegrated titanium fixtures (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg. 1986; 15(1): 39-52.
[6] Adell R, Lekholm U, Rockler B, Brånemark PI. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981; 10: 387-416.
[7] Weber HP, Buser D, Fiorellini JP, Williams RC. Radiographic evaluation of crestal bone levels adjacent to nonsubmerged titanium implants. Clin Oral Implants Res 1992; 3: 181-8.
[8] Bower RC. Peri-implantitis. Ann R Australas Coll Dent Surg. 1996; 13: 48-57.
[9] Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 2000 1998; 17: 63-76.
[10] Lang NP, Wilson TG, Corbet EF. Biological complications with dental implants: Their prevention, diagnosis and treatment. Clin Oral Implants Res 2000; 11(1): 146-55.
[11] Mombelli A. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol 2000 2002; 28: 177-89.
[12] Roos-Jansåker AM, Renvert S, Egelberg J. Treatment of peri-implant infections: a literature review. J Clin Periodontol. 2003; 30(6): 467-85.
[13] Heitz-Mayfield LJ. Diagnosis and management of peri-implant diseases. Aust Dent J. 2008; 53(1): S43-8.
[14] Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol. 2008; 35(8): 305-15.
[15] Tang Z, Cao C, Sha Y, Lin Y, Wang X. Effects of non-surgical treatment modalities on peri-implantitis. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002; 37(3): 173-5.
[16] Renvert S, Lessem J, Dahlén G, Renvert H, Lindahl C. Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol. 2008; 79(5): 836-44.
[17] Mombelli A, Lang NP. Antimicrobial treatment of peri-implant infections. Clin Oral Implants Res. 1992; 3(4): 162-8.
[18] Heitz-Mayfield LJ, Lang NP. Antimicrobial treatment of peri-implant diseases. Int J Oral Maxillofac Implants. 2004; 19: 128-39.
[19] Persson LG, Araújo MG, Berglundh T, Gröndahl K, Lindhe J. Resolution of peri-implantitis following treatment. An experimental study in the dog. Clin Oral Implants Res. 1999; 10(3): 195-203.
[20] Mombelli A, Schmid B, Rutar A, Lang NP. Local antibiotic therapy guided by microbiological diagnosis. Treatment of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans persisting after mechanical therapy. J Clin Periodontol 2002; 29: 743-9.
[21] Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol. 2008; 35(8): 316-32.
[22] Romeo E, Ghisolfi M, Murgolo N, Chiapasco M, Lops D, Vogel G. Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part I: clinical outcome. Clin Oral Implants Res. 2005; 16(1): 9-18.
[23] Schou S, Berglundh T, Lang NP. Surgical treatment of peri-implantitis. Int J Oral Maxillofac Implants. 2004; 19: 140-9.
[24] Hürzeler MB, Quiñones CR, Morrison EC, Caffesse RG. Treatment of peri-implantitis using guided bone regeneration and bone grafts, alone or in combination, in beagle dogs. Part 1: Clinical findings and histologic observations. Int J Oral Maxillofac Implants. 1995; 10(4): 474-84.
[25] von Arx T, Kurt B, Hardt N. Treatment of severe peri-implant bone loss using autogenous bone and a resorbable membrane. Case report and literature review. Clin Oral Implants Res. 1997; 8(6): 517-26.
[26] Behneke A, Behneke N, d'Hoedt B. Treatment of peri-implantitis defects with autogenous bone grafts: six-month to 3-year results of a prospective study in 17 patients. Int J Oral Maxillofac Implants. 2000; 15(1): 125-38.
[27] Tinti C, Parma-Benfenati S. Treatment of peri-implant defects with the vertical ridge augmentation procedure: a patient report. Int J Oral Maxillofac Implants. 2001; 16(4): 572-7.
[28] Chen S, Darby I. Dental implants: maintenance, care and treatment of peri-implant infection. Aust Dent J. 2003; 48(4): 212-20.
[29] Alcoforado GA, Rams TE, Feik D, Slots J. Microbial aspects of failing osseointegrated dental implants in humans. J Parodontol. 1991; 10(1): 11-18.
[30] Tanner A. Microbial etiology of periodontal diseases. Where are we? Where are we going? Curr Opin Dent. 1992; 2: 12-24.
[31] Leonhardt A, Renvert S, Dahlén G. Microbial findings at failing implants. Clin Oral Implants Res. 1999; 10(5): 339-45.
[32] Berglundh T, Lindhe J, Marinello C, Ericsson I, Liljenberg B. Soft tissue reaction to de novo plaque formation on implants and teeth. An experimental study in the dog. Clin Oral Implants Res 1992; 3: 1-8.
[33] Mombelli A, van Oosten MAC, Schürch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987; 2: 145-151.
[34] Rams TE, Link CC. Microbiology of failing dental implants in humans: electron microscopic observations. J Oral Implantol 1983; 11: 93-100.
[35] Hultin M, Gustafsson A, Hallstrom H, Johansson LÅ, Ekfledt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002; 13: 349-58.
[36] Matarasso S, Quaremba G, Coraggio F, Vaia E, Cafiero C, Lang NP. Maintenance of implants: an in vitro study of titanium implant surface modifications subsequent to the application of different prophylaxis procedures. Clin Oral Implants Res 1996; 7: 64-72.
[37] Meffert RM. Maintenance and treatment of the ailing and failing implant. J Indiana Dent Assoc. 1994; 73(3): 22-4.
[38] Bretz WA, Matuck AN, de Oliveira G, Moretti AJ, Bretz WA. Treatment of retrograde peri-implantitis: clinical report. Implant Dent. 1997; 6(4): 287-90.
[39] Lang NP, Mombelli A, Tonetti MS, Brägger U, Hämmerle CH. Clinical trials on therapies for peri-implant infections. Ann Periodontol. 1997; 2(1): 343-56.
[40] Porras R, Anderson GB, Caffesse R, Narendran S, Trejo PM. Clinical response to 2 different therapeutic regimens to treat peri-implant mucositis. J Periodontol. 2002; 73(10): 1118-25.
[41] Di Carlo F, Quaranta A, Di Alberti L, Ronconi LF, Quaranta M, Piattelli A. Influence of amine fluoride/stannous fluoride mouthwashes with and without chlorhexidine on secretion of proinflammatory molecules by peri-implant crevicular fluid cells. Minerva Stomatol. 2008; 57(5): 215-21, 221-5.
[42] Guarnelli ME, Zangari F, Manfrini R, Scapoli C, Trombelli L. Evaluation of additional amine fluoride/stannous fluoride-containing mouth rinse during supportive therapy in patients with generalized aggressive periodontitis. A randomized, crossover, double-blind, controlled trial. J Clin Periodontol. 2004; 31(9): 742-8.
[43] Mombelli A, Feloutzis A, Brägger U, Lang NP. Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results. Clin Oral Implants Res. 2001; 12(4): 287-94.
[44] Renvert S, Lessem J, Lindahl C, Svensson M. Treatment of incipient peri-implant infections using topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement. J Int Acad Periodontol. 2004; 6(4): 154-9.
[45] Renvert S, Lessem J, Dahlén G, Lindahl C, Svensson M. Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. J Clin Periodontol. 2006; 33(5): 362-9.
[46] Zablotsky MH, Diedrich DL, Meffert RM. Detoxification of endotoxin-contaminated titanium and hydroxyapatite-coated surfaces utilizing various chemotherapeutic and mechanical modalities. Implant Dent. 1992; 1(2): 154-8.
[47] Dennison DK, Huerzeler MB, Quinones C, Caffesse RG. Contaminated implant surfaces: an in vitro comparison of implant surface coating and treatment modalities for decontamination. J Periodontol. 1994; 65(10): 942-8.
[48] Kolonidis SG, Renvert S, Hämmerle CH, Lang NP, Harris D, Claffey N. Osseointegration on implant surfaces previously contaminated with plaque. An experimental study in the dog. Clin Oral Implants Res. 2003; 14(4): 373-80.
[49] Alhag M, Renvert S, Polyzois I, Claffey N. Re-osseointegration on rough implant surfaces previously coated with bacterial biofilm: an experimental study in the dog. Clin Oral Implants Res. 2008; 19(2): 182-7.
[50] Leonhardt A, Dahlén G, Renvert S. Five-year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man. J Periodontol. 2003; 74(10): 1415-22.
[51] Haas R, Dörtbudak O, Mensdorff-Pouilly N, Mailath G. Elimination of bacteria on different implant surfaces through photosensitization and soft laser. An in vitro study. Clin Oral Implants Res. 1997; 8(4): 249-54.
[52] Dörtbudak O, Haas R, Bernhart T, Mailath-Pokorny G. Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin Oral Implants Res. 2001; 12(2): 104-8.
[53] Sigusch BW, Pfitzner A, Albrecht V, Glockmann E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol. 2005; 76(7): 1100-5.
[54] Hayek RR, Araújo NS, Gioso MA, Ferreira J, Baptista-Sobrinho CA, Yamada AM, Ribeiro MS. Comparative study between the effects of photodynamic therapy and conventional therapy on microbial reduction in ligature-induced peri-implantitis in dogs. J Periodontol. 2005; 76(8): 1275-81.
[55] Shibli JA, Martins MC, Nociti FH Jr, Garcia VG, Marcantonio E Jr. Treatment of ligature-induced peri-implantitis by lethal photosensitization and guided bone regeneration: a preliminary histologic study in dogs. J Periodontol. 2003; 74(3): 338-45.
[56] Shibli JA, Martins MC, Ribeiro FS, Garcia VG, Nociti FH Jr, Marcantonio E Jr. Lethal photosensitization and guided bone regeneration in treatment of peri-implantitis: an experimental study in dogs. Clin Oral Implants Res. 2006; 17(3): 273-81.
[57] Kreisler M, Kohnen W, Marinello C, Götz H, Duschner H, Jansen B, d'Hoedt B. Bactericidal effect of the Er: YAG laser on dental implant surfaces: an in vitro study. J Periodontol. 2002; 73(11): 1292-8.
[58] Schwarz F, Sculean A, Romanos G, Herten M, Horn N, Scherbaum W, Becker J. Influence of different treatment approaches on the removal of early plaque biofilms and the viability of SAOS2 osteoblasts grown on titanium implants. Clin Oral Investig. 2005; 9(2): 111-7.
[59] Schwarz F, Rothamel D, Becker J. Influence of an Er: YAG laser on the surface structure of titanium implants. Schweiz Monatsschr Zahnmed. 2003; 113(6): 660-71.
[60] Takasaki AA, Aoki A, Mizutani K, Kikuchi S, Oda S, Ishikawa I. Er: YAG laser therapy for peri-implant infection: a histological study. Lasers Med Sci. 2007; 22(3): 143-57.
[61] Giannini R, Vassalli M, Chellini F, Polidori L, Dei R, Giannelli M. Neodymium: yttrium aluminum garnet laser irradiation with low pulse energy: a potential tool for the treatment of peri-implant disease. Clin Oral Implants Res. 2006; 17(6): 638-43.
[62] Mouhyi J, Sennerby L, Wennerberg A, Louette P, Dourov N, van Reck J. Re-establishment of the atomic composition and the oxide structure of contaminated titanium surfaces by means of carbon dioxide laser and hydrogen peroxide: an in vitro study. Clin Implant Dent Relat Res. 2000; 2(4): 190-202.
[63] Park CY, Kim SG, Kim MD, Eom TG, Yoon JH, Ahn SG. Surface properties of endosseous dental implants after NdYAG and CO2 laser treatment at various energies. J Oral Maxillofac Surg. 2005; 63(10): 1522-7.
[64] Romanos GE, Nentwig GH. Regenerative therapy of deep peri-implant infrabony defects after CO2 laser implant surface decontamination. Int J Periodontics Restorative Dent. 2008; 28(3): 245-55.
[65] Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials. 1999; 20(23-24): 2311-21.
[66] Baier RE. Surface properties influencing biological adhesion, in Adhesion in biological systems, M.R. S., Editor. 1970, Academic press: New York. 15-48.
[67] De Groot K, Geesink R, Klein CPAT, Serekian P. Plasma sprayed coatings of hydroxylapatite. Journal of Biomedical Materials Research 1987. 21(12): 1375-81.
[68] Wennerberg A, Albrektsson T, Lausmaa J. Torque and histomorphometric evaluation of c. p. titanium screws blasted with 25- and 75-μm-sized particles of Al2O3. Journal of Biomedical Materials Research 1996. 30(2): 251-60.
DOI: 10.1002/(sici)1097-4636(199602)30:2<251::aid-jbm16>3.0.co;2-p
[69] Szmukler-Moncler S, Simpson JP. Physico-chemical characterization of a Ti textured surface prepared by sandblasting and acid etching: in Transactions of the Annual Meeting of the Society for Biomaterials in conjunction with the International Biomaterials Symposium 2. (1996).
[70] Wennerberg A, Albrektsson T, Andersson B. Design and surface characteristics of 13 commercially available oral implant systems. Int J Oral Maxillofac Implants, 1993. 8(6): 622-33.
[71] Chehroudi B, Gould TRL, Brunette DM. Titanium-coated micromachined grooves of different dimensions affect epithelial and connective-tissue cells differently in vivo. J Biomed Mat Res 1990. 24(9): 1203-19.
[72] Chauvy PF, Hoffmann P, Landolt D. Electrochemical micromachining of titanium through a laser patterned oxide film. Electrochemical and Solid-State Letters, 2001. 4 (5): C31-C34.
DOI: 10.1149/1.1359057
[73] Chauvy PF, Hoffmann P, Landolt D. Applications of laser lithography on oxide film to titanium micromachining Applied Surface Science, 2003. 208-209(1): 165-70.
[74] Ku Y, Chung CP, Jang JH. The effect of the surface modification of titanium using a recombinant fragment of fibronectin and vitronectin on cell behaviour. Biomaterials, 2005. 26(25): 5153-7.
[75] Bierbaum S, Beutner R, Hanke T, Scharnweber D, Hempel U, Worch H. Modification of Ti6Al4V surfaces using collagen I, III, and fibronectin. I. Biochemical and morphological characteristics of the adsorbed matrix. J Biomed Mater Res A. 2003; 67(2): 421-30.
DOI: 10.1002/jbm.a.10080
[76] Bierbaum S, Hempel U, Geissler U, Hanke T, Scharnweber D, Wenzel KW, Worch H. Modification of Ti6AL4V surfaces using collagen I, III, and fibronectin. II. Influence on osteoblast responses. J Biomed Mater Res A. 2003; 67(2): 431-8.
DOI: 10.1002/jbm.a.10084
[77] Morra M, Cassinelli C, Cascardo G, Cahalan P, Cahalan L, Fini M, Giardino R. Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies. Biomaterials. 2003; 24(25): 4639-54.
[78] Morra M. Biochemical modification of titanium surfaces: peptides and ECM proteins. Eur Cell Mater, 2006. 12: 1-15.
DOI: 10.22203/ecm.v012a01
[79] Dettin M, Conconi MT, Gambaretto R, Bagno A, Di Bello C, Menti AM, Grandi C, Parnigotto PP. Effect of synthetic peptides on osteoblast adhesion. Biomaterials. 2005; 26(22): 4507-15.
[80] Schliephake H, Scharnweber D, Dard M, Rössler S, Sewing A, Meyer J, Hoogestraat D. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. Clin Oral Implants Res. 2002; 13(3): 312-9.
[81] Liu Y, Enggist L, Kuffer AF, Buser D, Hunziker EB. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials. 2007; 28(16): 2677-86.
[82] Hall J, Sorensen RG, Wozney JM, Wikesjö UM. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol. 2007; 34(5): 444-51.
[83] Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res. 1997; 8(5): 367-74.
[84] Wikesjö UM, Qahash M, Thomson RC, Cook AD, Rohrer MD, Wozney JM, Hardwick WR. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res. 2004; 15(2): 194-204.
[85] Selvig KA, Sorensen RG, Wozney JM, Wikesjö UM. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol. 2002; 73(9): 1020-9.
[86] Sigurdsson TJ, Nguyen S, Wikesjo UM. Alveolar ridge augmentation with rhBMP-2 and bone-to-implant contact in induced bone. Int J Periodontics Restorative Dent. 2001; 21(5): 461-73.
[87] Wikesjö UM, Polimeni G, Qahash M. Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives. Clin Implant Dent Relat Res. 2005; 7(2): 112-9.
[88] Kay JF. Calcium phosphate coatings: understanding the chemistry and biology and their effective use. Compend Suppl. 1993; (15): S520-5.
[89] Klein CP, Patka P, Wolke JG, de Blieck-Hogervorst JM, de Groot K. Long-term in vivo study of plasma-sprayed coatings on titanium alloys of tetracalcium phosphate, hydroxyapatite and alpha-tricalcium phosphate. Biomaterials 1994; 15: 146-150.
[90] Klein CP, Patka P, van der Lubbe HB, Wolke JG, de Groot K. Plasma-sprayed coatings of tetracalciumphosphate, hydroxyl-apatite, and alpha-TCP on titanium alloy: an interface study. J Biomed Mater Res. 1991; 25(1): 53-65.
[91] Arias JL, Mayor MB, Pou J, Leng Y, León B, Pérez-Amor M. Micro- and nano-testing of calcium phosphate coatings produced by pulsed laser deposition. Biomaterials. 2003; 24(20): 3403-8.
[92] Citeau A, Guicheux J, Vinatier C, Layrolle P, Nguyen TP, Pilet P, Daculsi G. In vitro biological effects of titanium rough surface obtained by calcium phosphate grid blasting. Biomaterials. 2005; 26(2): 157-65.
[93] Berry CW, Moore TJ, Safar JA, Henry CA, Wagner MJ. Antibacterial activity of dental implant metals. Implant Dent. 1992; 1(1): 59-65.
[94] Antoci V Jr, Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res. 2007; 461: 81-7.
[95] Antoci V Jr, King SB, Jose B, Parvizi J, Zeiger AR, Wickstrom E, Freeman TA, Composto RJ, Ducheyne P, Shapiro IM, Hickok NJ, Adams CS. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res. 2007; 25(7): 858-66.
DOI: 10.1002/jor.20348
[96] Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, Raschke M. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003; 32(5): 521-31.
[97] Thiel J, Pakstis L, Buzby S, Raffi M, Ni C, Pochan DJ, Shah SI. Antibacterial properties of silver-doped titania. Small. 2007; 3(5): 799-803.
[98] Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A, 2006. 78(3): 595-604.
DOI: 10.1002/jbm.a.30789
[99] Yoshinari M, Oda Y, Kato T, Okuda K. Influence of surface modifications to titanium on antibacterial activity in vitro. Biomaterials. 2001; 22(14): 2043-8.
[100] Liu Y, Hunziker EB, Layrolle P, De Bruijn JD, De Groot K. Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. Tissue Eng. 2004; 10 (1-2): 101-8.
[101] Liu Y, de Groot K, Hunziker EB. Osteoinductive implants: the mise-en-scène for drug-bearing biomimetic coatings. Ann Biomed Eng. 2004; 32(3): 398-406.
[102] Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone, 2005. 36(5): 745-57.
[103] Liu Y, Huse RO, de Groot K, Buser D, Hunziker EB. Delivery mode and efficacy of BMP-2 in association with implants. J Dent Res. 2007; 86(1): 84-9.
[104] Liu Y, Li JP, Hunziker EB, de Groot K. Incorporation of growth factors into medical devices via biomimetic coatings. Philos Transact A Math Phys Eng Sci. 2006; 364 (1838): 233-48.
[105] Hürzeler MB, Quiñones CR, Schüpback P, Morrison EC, Caffesse RG. Treatment of peri-implantitis using guided bone regeneration and bone grafts, alone or in combination, in beagle dogs. Part 2: Histologic findings. Int J Oral Maxillofac Implants. 1997; 12(2): 168-75.
[106] von Arx T, Kurt B, Hardt N. Treatment of severe peri-implant bone loss using autogenous bone and a resorbable membrane. Case report and literature review. Clin Oral Implants Res. 1997; 8(6): 517-26.
[107] Behneke A, Behneke N, d'Hoedt B. Treatment of peri-implantitis defects with autogenous bone grafts: six-month to 3-year results of a prospective study in 17 patients. Int J Oral Maxillofac Implants. 2000; 15(1): 125-38.
[108] Nociti FH Jr, Machado MA, Stefani CM, Sallum EA, Sallum AW. Absorbable versus nonabsorbable membranes and bone grafts in the treatment of ligature-induced peri-implantitis defects in dogs. Part I. A clinical investigation. Clin Oral Implants Res. 2001; 12(2): 115-20.
[109] Schou S, Holmstrup P, Jørgensen T, Skovgaard LT, Stoltze K, Hjørting-Hansen E, Wenzel A. Anorganic porous bovine-derived bone mineral (Bio-Oss) and ePTFE membrane in the treatment of peri-implantitis in cynomolgus monkeys. Clin Oral Implants Res. 2003; 14(5): 535-47.
[110] Schou S, Holmstrup P, Jørgensen T, Stoltze K, Hjørting-Hansen E, Wenzel A. Autogenous bone graft and ePTFE membrane in the treatment of peri-implantitis. I. Clinical and radiographic observations in cynomolgus monkeys. Clin Oral Implants Res. 2003; 14(4): 391-403.
[111] Schou S, Holmstrup P, Skovgaard LT, Stoltze K, Hjørting-Hansen E, Gundersen HJ. Autogenous bone graft and ePTFE membrane in the treatment of peri-implantitis. II. Stereologic and histologic observations in cynomolgus monkeys. Clin Oral Implants Res. 2003; 14(4): 404-11.
[112] You TM, Choi BH, Zhu SJ, Jung JH, Lee SH, Huh JY, Lee HJ, Li J. Treatment of experimental peri-implantitis using autogenous bone grafts and platelet-enriched fibrin glue in dogs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103(1): 34-7.
[113] Baron M, Haas R, Dörtbudak O, Watzek G. Experimentally induced peri-implantitis: a review of different treatment methods described in the literature. Int J Oral Maxillofac Implants. 2000; 15(4): 533-44.
[114] Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UM. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants. 1997; 12(5): 604-10.
[115] Günay H, Skubulla F, Neukam W. Experimentelle Untersuchung zur Behandlung von periimplantären Knochendefekten. Zahnärztl Implantol 1991; 7: 16–24.
[116] Fiorellini JP, Kim DM, Nakajima Y, Weber HP. Osseointegration of titanium implants following guided bone regeneration using expanded polytetrafluoroethylene membrane and various bone fillers. Int J Periodontics Restorative Dent. 2007; 27(3): 287-94.
[117] Schou S, Holmstrup P, Jørgensen T, Skovgaard LT, Stoltze K, Hjørting-Hansen E, Wenzel A. Implant surface preparation in the surgical treatment of experimental peri-implantitis with autogenous bone graft and ePTFE membrane in cynomolgus monkeys. Clin Oral Implants Res. 2003; 14(4): 412-22.